2010 2016 Ethics Innovation 
Harvard Business Review
APRIL 10, 2018
We also found that this greater firm value comes from better corporate innovations and successful diversified M&As. Using BoardEx data provided by the Center for Corporate Performance, we examined a sample of 1,212 CEOs who led S&P 1500 firms between 2000 and 2010. Our findings have broad implications.
Harvard Business Review
FEBRUARY 3, 2017
By that I mean that pharma companies should develop innovative treatments for pervasive unmet medical needs; avoid corruption, collusion, and other unethical marketing practices; and make sure that their products reach as many patients around the world as possible. citizens have a positive opinion of big pharma. Enhance corporate reputations.
Expert insights. Personalized for you.
9 
Let's personalize your content